AUTHOR=Hussain Imran , Deb Paromita , Chini Avisankar , Obaid Monira , Bhan Arunoday , Ansari Khairul I. , Mishra Bibhu P. , Bobzean Samara A. , Udden S. M. Nashir , Alluri Prasanna G. , Das Hriday K. , Brothers Robert Matthew , Perrotti Linda I. , Mandal Subhrangsu S. 

TITLE=HOXA5 Expression Is Elevated in Breast Cancer and Is Transcriptionally Regulated by Estradiol

JOURNAL=Frontiers in Genetics

VOLUME=11

YEAR=2020

URL=https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2020.592436

DOI=10.3389/fgene.2020.592436

ISSN=1664-8021

ABSTRACT=<p>HOXA5 is a homeobox-containing gene associated with the development of the lung, gastrointestinal tract, and vertebrae. Here, we investigate potential roles and the gene regulatory mechanism in HOXA5 in breast cancer cells. Our studies demonstrate that HOXA5 expression is elevated in breast cancer tissues and in estrogen receptor (ER)-positive breast cancer cells. HOXA5 expression is critical for breast cancer cell viability. Biochemical studies show that estradiol (E2) regulates HOXA5 gene expression in cultured breast cancer cells <italic>in vitro</italic>. HOXA5 expression is also upregulated <italic>in vivo</italic> in the mammary tissues of ovariectomized female rats. E2-induced HOXA5 expression is coordinated by ERs. Knockdown of either ERα or ERβ downregulated E2-induced HOXA5 expression. Additionally, ER co-regulators, including CBP/p300 (histone acetylases) and MLL-histone methylases (MLL2, MLL3), histone acetylation-, and H3K4 trimethylation levels are enriched at the HOXA5 promoter in present E2. In summary, our studies demonstrate that HOXA5 is overexpressed in breast cancer and is transcriptionally regulated via estradiol in breast cancer cells.</p>